title: FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
abstract: The transcription factor E2F1 is a key regulator of proliferation and apoptosis but the molecular mechanisms that mediate these cell fate decisions remain unclear. Here, we identify FOXO transcription factors as E2F1 target genes that act in a feed-forward regulatory loop to reinforce gene induction of multiple apoptotic genes. We found that E2F1 forms a complex with FOXO1 and FOXO3. RNAi-mediated silencing of FOXO impaired E2F1 binding to the promoters of cooperative target genes. A FOXO3 mutant insensitive to inactivation by survival kinases rescued the inhibitory effect of growth factor signaling on E2F1-mediated transcription and apoptosis. The E2F1/FOXO axis is frequently blocked in cancer, as evidenced by the specific downregulation of the FOXO-dependent E2F1 transcriptional program in multiple cancer types and by the association of a reduced E2F1/FOXO transcriptional program with poor prognosis. HDAC and phosphoinositide 3-kinase (PI3K) inhibitors were identified as specific activators of E2F1/FOXO transcription, acting to enhance E2F1-induced apoptosis in a FOXO3-dependent manner. Notably, combining the histone deacetylase inhibitor vorinostat with a PI3K inhibitor led to enhanced FOXO-dependent apoptosis. Collectively, our results identify E2F1/FOXO cooperation as a regulatory mechanism that places E2F1 apoptotic activity under the control of survival signaling. Therapeutic reactivation of this tumor suppressive mechanism may offer a novel broad-acting therapy for cancer.
authors: Authors' Affiliations: Duke Institute for Genome Sciences and Policy, Department of Molecular Genetics and Microbiology, Duke University Medical Center; Department of Biomedical Engineering, Duke University, Durham, North Carolina.
authors: Igor
authors: I
authors: Shats
authors: Michael L
authors: ML
authors: Gatza
authors: Beiyu
authors: B
authors: Liu
authors: Steven P
authors: SP
authors: Angus
authors: Lingchong
authors: L
authors: You
authors: Joseph R
authors: JR
authors: Nevins
mesh_terms: D017209:Apoptosis; D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D015153:Blotting, Western; D001859:Bone Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D001943:Breast Neoplasms / Q000235:genetics / Q000401:mortality* / Q000473:pathology; D049109:Cell Proliferation; D047369:Chromatin Immunoprecipitation; D002867:Chromones / Q000494:pharmacology; D050687:E2F1 Transcription Factor / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D005455:Fluorescent Antibody Technique; D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D056572:Histone Deacetylase Inhibitors / Q000494:pharmacology; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D007124:Immunoenzyme Techniques; D047468:Immunoprecipitation; D008175:Lung Neoplasms / Q000235:genetics / Q000401:mortality* / Q000473:pathology; D009025:Morpholines / Q000494:pharmacology; D020411:Oligonucleotide Array Sequence Analysis; D012516:Osteosarcoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011379:Prognosis; D011401:Promoter Regions, Genetic / Q000235:genetics; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D015996:Survival Rate; D014407:Tumor Cells, Cultured; D000077337:Vorinostat
chemical_list: D014408:Biomarkers, Tumor; D002867:Chromones; D050687:E2F1 Transcription Factor; D004791:Enzyme Inhibitors; D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D009025:Morpholines; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D051057:Proto-Oncogene Proteins c-akt; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D000077337:Vorinostat; C493753:E2F1 protein, human; C499517:FOXO3 protein, human; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
references: Cell. 1997 Aug 8;90(3):405-13
references: 9267021
references: Curr Mol Med. 2006 Nov;6(7):739-48
references: 17100600
references: Nat Med. 2008 Aug;14(8):822-7
references: 18641660
references: Nature. 2000 Oct 5;407(6804):645-8
references: 11034215
references: Cell. 2010 Mar 5;140(5):744-52
references: 20211142
references: Apoptosis. 2007 Feb;12(2):411-21
references: 17191121
references: Science. 2012 Nov 16;338(6109):975-80
references: 22983707
references: J Neurosci. 2011 Mar 30;31(13):5032-44
references: 21451041
references: Cell. 2000 Jan 7;100(1):57-70
references: 10647931
references: EMBO J. 1996 Aug 1;15(15):3861-70
references: 8670891
references: Nat Cell Biol. 2001 Jun;3(6):552-8
references: 11389439
references: Cell. 1996 May 17;85(4):549-61
references: 8653790
references: Genes Dev. 2001 Jul 15;15(14):1833-44
references: 11459832
references: Cell. 2004 Apr 16;117(2):225-37
references: 15084260
references: Nature. 2005 Jun 30;435(7046):1244-50
references: 15902206
references: Nat Cell Biol. 2002 Nov;4(11):859-64
references: 12389032
references: Cell. 2007 Jan 26;128(2):309-23
references: 17254969
references: Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5136-41
references: 12702751
references: Biochim Biophys Acta. 2011 Nov;1813(11):1978-86
references: 21440011
references: Nat Cell Biol. 2003 Jun;5(6):552-8
references: 12766778
references: Exp Biol Med (Maywood). 2006 Jul;231(7):1271-81
references: 16816134
references: Biochim Biophys Acta. 2007 Apr;1769(4):244-52
references: 17482685
references: Nat Rev Genet. 2007 Jun;8(6):450-61
references: 17510665
references: Cell. 1999 Mar 19;96(6):857-68
references: 10102273
references: Nature. 2006 Mar 9;440(7081):233-6
references: 16407888
references: Nat Rev Cancer. 2002 Dec;2(12):910-7
references: 12459729
references: Nat Rev Cancer. 2009 Oct;9(10):738-48
references: 19776743
references: J Biol Chem. 2004 Mar 5;279(10):8627-34
references: 14684737
references: Mol Cell Biol. 2002 Nov;22(22):7842-52
references: 12391153
references: Science. 2003 Aug 8;301(5634):843-6
references: 12907805
references: J Virol. 1995 Apr;69(4):2491-500
references: 7884898
references: Nat Rev Mol Cell Biol. 2007 Jun;8(6):440-50
references: 17522590
references: Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6994-9
references: 20335537
references: Mol Cell Biol. 2001 Feb;21(3):952-65
references: 11154281
references: FEBS Lett. 2002 Oct 2;529(1):122-5
references: 12354623
references: Oncogene. 2002 Feb 21;21(9):1359-69
references: 11857079
references: Genes Dev. 2001 Feb 1;15(3):267-85
references: 11159908
references: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10848-53
references: 12954980
references: Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2724-9
references: 22003129
references: Biochem J. 2004 Jun 1;380(Pt 2):297-309
references: 15005655
references: Science. 2006 Sep 29;313(5795):1929-35
references: 17008526
references: Biochem J. 2003 Aug 1;373(Pt 3):739-46
references: 12755686
references: J Biol Chem. 1997 Dec 26;272(52):33056-61
references: 9407088
references: Cancer Cell. 2008 Jan;13(1):11-22
references: 18167336